Vir Biotechnology, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Francisco, CA
VIR chart
What traders are saying about $VIR
Latest postsVir Biotechnology, Inc. news
- Vir Biotechnology (NASDAQ:VIR) Breaks Higher: Real Momentum?
Kalkine Media ·
- Vir Biotechnology: A Big Pharma Collaboration And 2 Clinical Catalysts This Quarter (VIR)
Seeking Alpha ·
- Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50-Day Moving Average - What's Next?
MarketBeat ·
- Vir Biotechnology, Inc. (VIR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Is Vir Biotechnology (VIR) Undervalued On Its Gilead Oncology Deal?
Yahoo Finance ·
- Vir Biotechnology (VIR) As Gilead Deal Puts Its Valuation Narrative Back In Focus
Simply Wall Street ·
- Vir Biotechnology, Inc. (VIR) - What Are Investment Firms Thinking About This Stock?
MarketBeat ·
- VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership
Stocktwits ·
- Vir Biotechnology, Inc. Estimates – NASDAQ:VIR
TradingView ·
- Vir Biotechnology stock: Gilead deal brings up to USD 135 million upfront
ad-hoc-news.de ·
- Vir Biotechnology advances dual-masked TCE pipeline targeting difficult-to-treat solid tumors
Traders Union ·
- Vir Biotechnology (NasdaqGS:VIR) Stock Forecast & Analyst Predictions
Simply Wall Street ·
Vir Biotechnology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $68.6M | $74.2M | $86.2M | $1.62B |
| Net income | -$438.0M | -$522.0M | -$615.1M | $515.8M |
| Diluted EPS | $-3.16 | $-3.83 | $-4.59 | $3.83 |
| Total assets (year end) | $1.00B | $1.40B | $1.92B | $2.80B |
| Cash and equivalents (year end) | $232.2M | $222.9M | $241.6M | $848.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vir Biotechnology, Inc.
- Ticker
- VIR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1706431
Frequently asked questions
What exchange is Vir Biotechnology, Inc. listed on?
Vir Biotechnology, Inc. trades on the Nasdaq under the ticker symbol VIR.
What industry is Vir Biotechnology, Inc. in?
Vir Biotechnology, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Vir Biotechnology, Inc. headquartered?
Vir Biotechnology, Inc.'s business address on file with the SEC is in San Francisco, CA.
When does Vir Biotechnology, Inc.'s fiscal year end?
Vir Biotechnology, Inc.'s fiscal year ends on December 31.
How much revenue did Vir Biotechnology, Inc. report?
Vir Biotechnology, Inc. reported $68.6M in revenue for calendar year 2025, according to its SEC filings.